HS research update (2026-10-01): What’s new on PubMed?
A patient-friendly overview of new PubMed publications on hidradenitis suppurativa (acne inversa) — with sources, clear limitations, and no medical advice.
Categories
Patient-friendly context on new studies — no medical advice, with clear limitations.
A patient-friendly overview of new PubMed publications on hidradenitis suppurativa (acne inversa) — with sources, clear limitations, and no medical advice.
A patient-friendly overview of new PubMed publications on hidradenitis suppurativa (acne inversa) — with sources, clear limitations, and no medical advice.
The European S2k guideline for HS/acne inversa (Part 1, 2026) substantially updates the predecessor guideline from 2015. An overview of six changes with direct relevance to patients, with links to the detailed article on each.
A patient-friendly overview of new PubMed publications on hidradenitis suppurativa (acne inversa) — with sources, clear limitations, and no medical advice.
A patient-friendly summary of the June 2026 systematic review on GLP-1 receptor agonists (like semaglutide) and hidradenitis suppurativa — 19 studies, 67,568 patients, and what the numbers do and don't prove.
A patient-friendly overview of new PubMed publications on hidradenitis suppurativa (acne inversa) — with sources, clear limitations, and no medical advice.
A patient-friendly overview of new PubMed publications on hidradenitis suppurativa (acne inversa) — with sources, clear limitations, and no medical advice.
A step-by-step, patient-centred walkthrough of what joining a hidradenitis suppurativa clinical trial may involve — from finding a study and screening to visits, questionnaires, reimbursement, withdrawing and life after the trial.
A patient-friendly history of the clinical trials behind modern hidradenitis suppurativa treatment — adalimumab (PIONEER), secukinumab (SUNSHINE/SUNRISE), bimekizumab (BE HEARD) and a trial that did not succeed — with trial results kept separate from regulatory approvals.
A clear, non-technical guide to clinical trials for people with hidradenitis suppurativa (acne inversa): phases, screening, consent, randomisation, placebos, benefits, risks and the questions worth asking first.
A patient-friendly overview of new PubMed publications on hidradenitis suppurativa (acne inversa) — with sources, clear limitations, and no medical advice.
A patient-friendly overview of new PubMed publications on Hidradenitis Suppurativa (Acne Inversa) (HS) — with sources, clear limitations, and no treatment recommendations.
A patient-friendly overview of new PubMed publications on Hidradenitis Suppurativa (HS) — with sources, clear limitations, and no treatment recommendations.
A patient-friendly overview of new PubMed publications on Acne inversa (Hidradenitis suppurativa) (HS) — with sources, clear limitations, and no treatment recommendations.
A patient-friendly overview of new PubMed publications on hidradenitis suppurativa (acne inversa) — with sources, clear limitations, and no medical recommendations.
A patient-friendly overview of new PubMed publications on Hidradenitis suppurativa (Acne inversa) – with sources, clear limitations, and no medical advice.
Search every guide, article, glossary term, patient story and tool on this website.
Search Acne Inversa Life